The appropriate conditions for determining angiotensin-converting enzyme in human serum with use of 2-furanacryloyl-L-phenylalanylglycylglycine as substrate are described. The method, a modification of that reported by Holmquist et al. (Anal. Biochem. 95:540-548, 1979) for purified rabbit lung enzyme, is based on the blue shift of the absorption spectrum that occurs upon hydrolysis of the substrate into furanacryloyl-L-phenylalanine and glycyiglycine. The Km value for the substrate is 0.31 mmol/L. Some kinetic properties determined by this method are similar to those previously reported for the purified serum enzyme. Results by the present assay and Cushman's modified method correlate closely (r = 0.995). The normal reference interval for 42 adult donors was 43-137 U/L (mean 90 U/L, SD 23 U/L). The within-run and between-run CVs ranged from 3.0 to 4.1%. Its rapidity, simplicity, sensitivity, and precision make the proposed method very suitable for routine work, clinical investigation, and kinetic and structural studies of the serum enzyme.
Direct Spectrophotometric Assay for Angiotensin-Converting Enzyme in Serum
Simonetta
Ronca-Testoni
The appropriate conditions for determining angiotensin-converting enzyme in human serum with use of 2-furanacryloyl-L-phenylalanylglycylglycine as substrate are described. The method, a modification of that reported by Holmquist et al. (Anal. Biochem. 95:540-548, 1979 ) for purified rabbit lung enzyme, is based on the blue shift of the absorption spectrum that occurs upon hydrolysis of the substrate into furanacryloyl-L-phenylalanine and glycyiglycine. The Km value for the substrate is 0.31 mmol/L. Some kinetic properties determined by this method are similar to those previously reported for the purified serum enzyme. Results by the present assay and Cushman's modified method correlate closely (r = 0.995). The normal reference interval for 42 adult donors was 43-137 U/L (mean 90 U/L, SD 23 U/L). The within-run and between-run CVs ranged from 3.0 to 4.1%. Its rapidity, simplicity, sensitivity, and precision make the proposed method very suitable for routine work, clinical investigation, and kinetic and structural studies of the serum enzyme.
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Angiotensin-converting enzyme (ACE, EC 3.4.15.1),' a dipeptidyl carboxypeptidase, releases C-terminal His-Leu from decapeptide angiotensin I and thereby converts it into the powerful vasoconstrictor and salt-retaining compound, angiotensin H (1). Lung ACE is considered the principal source for serum enzyme (2) .
Significant increases in serum ACE are observed in 75% of patients with active pulmonary sarcoidosis (3). Rarely, ACE in serum is increased in patients suffering from other types of lung disease such as pulmonary tuberculosis, coccidioides, lung cancer, or from other types of granulomatous disease, so the assay of serum ACE activity is a helpful test for the differential diagnosis of sarcoidosis. Increased ACE activity has been reported in Gaucher's disease (4),leprosy (5) , silicosis (6), asbestosis (6) , and in 24% of diabetes mellitus (7) . The enzyme also seems to play a key physiological role in the regulation of blood pressure (8) .
The first methods reported for ACE assay utilized the physiological substrates (9) but suffered from interference by other peptidases that degrade both substrate and products. In chemical methods with N-substituted tripeptides that are specifically hydrolyzed by the enzyme, the reaction rate has been measured by spectrophotometric (10), fluorometric (11, 12) , radioisotopic (13, 14), and liquid-chromatographic (15) procedures.
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Materials and Methods

Apparatus.
All the absorbance measurements were made with a Model PMQ II spectrophotometer equipped with a T-E converter (Carl Zeiss, OberkochenlWurtt, F.R.G.). Cuvettes with 1-mm or 5-mm pathlength were used for spectra.
Reagents. FAPGG was synthetized by the method of Holmquist et al. (16) . The compound was recrystallized twice from methanollwater and gave a single spot by thinlayer chromatography. It is soluble in neutral or slightly alkaline solutions and is stable for months if stored in the cold and in the dark. Hippuryl-ihistidyl-L-leucine (HHL) was obtained from Sigma Chemical Co., St. Louis, MO 63178. Captopril (2-methyl-3-mercaptopropanoyl-z..-proline, SQ 14,225) was kindly provided by Squibb, Princeton, NJ 08540. All other reagents were of analytical grade. All pH adjustments were made at 37 #{176}C. Serum samples. Blood was collected from healthy subjects by venipuncture and serum separated by centrifugation after 1 h at room temperature. Serum was stored at -20 #{176}C and the activities were stable for at least three months.
Enzyme assay. Unless otherwise indicated, add 50-100 j.tL of serum to 0.5 mL of a substrate-buffer solution containing, per liter, 1.6-2.0 mmol of FAPGG, 0.6 mol of NaCl, and 100 mmol of Tris or 160 mmol of borate buffer, pH 8.2. Add distilled water to a final volume of 1 mL. Incubate at 37 #{176}C and measure the absorbance after 3 mm and after an appropriate incubation time varying from 15 to 60 min. Determine zA/min and convert it into U/L according to the following formula (M/min x Vt x 1000)1(0.5 x V8), where Vt is the final assay volume (= 1), V8 is the sample volume, and 0.5 is the millimolar LA of FAPGG hydrolysis. One unit (1 U) of ACE is the amount of enzyme that converts 1 tmol of FAPGG into FA-Phe and Gly-Gly per minute at 37#{176}C.
Cushman's modified method:
The spectrophotometric assay developed by Cushman and Cheung (10) and modified by Lieberman (17) for human serum was used to obtain comparison data. In this assay, HHL was used as substrate.
Results
The substrate used in the present assay, FAPGG, shows an absorption spectrum with a maximum at 305 nm; its hydrolysis into FA-Pheand Gly-Gly determines a shift of this maximum at 300 nm. As it appears in the difference spectrum reported in Figure 1 , maximum & occurs at 328 nm. Thus the rate of hydrolysis may be measured by monitoring the absorbance decrease at this wavelength, but when relatively high concentrations of substrate are used (threefold Km) FAPGG hydrolysis is followed at 345 nm so 
at 328 nm).
The effect of FAPGG concentration on serum ACE activity was examined and the Michaelis constant was calculated by the plot of Lineweaver and Burk (Figure 2 ). The apparent Km is 0.31 mmol/L, showing a higher affinity of serum ACE for FAPGG than for other substrates [apparent Km for the most commonly used substrate for determination of serum ACE, HHL, is 1.2-1.6 mmol/L (11, 18, 19) 1. The concentration of FAPGG ordinarily used in the present assay is threefold Km (0.8 to 1 mmolfL) and the measurements are made at 345 nm.
The rate of FAPGG hydrolysis has been determined as a function of incubation interval and serum enzyme concen- (Figure 3) . At 0.8 mmol of FAPGG per liter the reaction is linear up to a 40% of total hydrolysis, which corresponds to a A of 0.160. In these conditions different serum volumes (from 25 to 100 L) produced a linear response for initial velocity vs enzyme concentration. ACE being a halide-requiring dipeptidase (8) , I examined the influence of chloride ion on FAPGG hydrolysis by serum (Figure 4) . In the absence of chloride ion the activity is very low, progressively increasing with ion concentration to a maximum at 0.3 molIL NaC1 in 50 mmolJL Tris or 80 mmoll L borate buffer,pH 8.2. At pH 7.5 the activity is maximum in the presence of 0.2 mol/L NaC1. Figure 5 shows the pH dependence of FAPGG hydrolysis by serum. In the presence of 1 mmol/L FAPGG, 0.3 molIL NaC1, and 50 mmollL Tris or 80 mmolJL borate buffer,the rate of hydrolysis was maximum at pH 8. Serum pools with normal and above-normal activities were assayed to estimate the variability of the method; results are reported in Table 1 .
A correlation analysis between the present method and Cushman's modified method was performed on 20 serum samples ( Figure 6 ). The correlation coefficient (r) was 0.995 Table 1 EDTA, 100 molIL, completely inhibits the hydrolysis of FAPGG, as does captopril, the most competitive inhibitor of ACE (20) , at a concentration of 100 nmol/L. Some metal divalent ions exert an inhibitory effect on serum ACE activity: at a concentration of 0.1 mmolIL Ni2 , Cd2', Co2, and Hg2' inhibit FAPGG hydrolysis by 90, 89, 50, and 36%, respectively. Because the enzyme is a glycoprotein with a catalytically essential zinc atom (2), these heavy metal ions probably decrease the enzyme activity by exchange reaction with Zn2' to yield less-active metalloproteins.
Regarding materials in serum which might affect ACE determination, no effect by bilirubin, lipids, or hemoglobin was observed. 
Discussion
Most of the existing methods for determining ACE activity in serum are indirect and require much time, several tedious steps, including sample preparation or product extraction, and often special instrumentation.
Thus they are not always suitable for routine use.
The substrate used in the present method is a tripeptide blocked at the N-terminal by a furanacryloyl group, which acts as a chromophoric monitor of substrate hydrolysis. The principle is the same as that reported by Holmquist et al. (16) for the assay of purified rabbit lung ACE, and in the present work I have established the appropriate reaction conditions for human serum enzyme. The method offers several advantages over currently used ACE assays. The substrate FAPGG is easily synthetized and is stable in solution for months if stored in the cold and in the dark. Its high solubility (up to 0.01 mollL) allows its use at elevated concentrations, higher than Km, thus leaving the reaction rate independent of substrate concentration. No other reagent is required in the assay. The absorbance is read at 345 nm, so that no special instrumentation is necessary, and the procedure does not suffer from the interferences inherent to fluorometric and far-ultraviolet spectrophotometric methods.
The reaction time is shortened to 20 mm with respect to the usual 60-mm incubation interval for the other assays.
Throughout a 20-mm incubation the reaction rate remains linear also for sera with above-normal activity (up to 320 U/ L) and re-assay of diluted samples is avoided.
The complete inhibition of FAPGG hydrolysis by human serum in the presence of captopril or EDTA indicates that the substrate used in the present assay is cleaved only by ACE in serum. The other reaction characteristics, such as optimal pH and chloride ion activation, closely resemble those previouslydescribed for purified serum ACE (21) . The Km value for FAPGG shows a better affinity of the enzyme for this substrate than for HHL. Furthermore, the rate of FAPGG hydrolysis is considerably faster than that for other frequently used substrates. In fact, the mean values obtained in this assay are three-to 4.5-fold higher than those reported in the literature with HIlL as substrate.
Results by the present method strictly correlate with those by Cushman's modified method, show good precision, and are essentially free from interference by bilirubin, lipemia, and hemoglobin. Ordinarily, hemolyzed samples should be excluded from analysis, because hemolysis usually indicates mistreatment of the specimen.
For its rapidity and simplicity the method here described is suitable for routine assay and for clinical studies of serum ACE. In patients with active sarcoidosis the enzyme values fall within the normal range during spontaneous remission of the disease or after an appropriate corticosteroid treatment (5), so the serum ACE assay can be used not only for confirming a diagnosis of active sarcoidosis but also for following the clinical course and effectiveness of therapy in the management of the disease. Furthermore, it recently has been reported that specific inhibitors of ACE are very effective in reducing blood pressure (20) and their use in the therapy of hypertension is becoming widespread. The evaluation of ACE inhibition in serum can be a useful test for accurately monitoring the efficiency of these hypotensive drugs.
